[HTML][HTML] Recruitment and retention of underrepresented populations in Alzheimer's disease research: a systematic review
Introduction Alzheimer's disease and related dementias (ADRD) disproportionately impact
racial and ethnic minority and socioeconomically disadvantaged adults. Yet, these …
racial and ethnic minority and socioeconomically disadvantaged adults. Yet, these …
Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review
Background Racial and ethnic minoritized groups are disproportionately at risk for
Alzheimer's Disease (AD), but are not sufficiently recruited in AD neuroimaging research in …
Alzheimer's Disease (AD), but are not sufficiently recruited in AD neuroimaging research in …
Association of neighborhood-level disadvantage with Alzheimer disease neuropathology
WR Powell, WR Buckingham, JL Larson… - JAMA network …, 2020 - jamanetwork.com
Importance Social determinants of health, such as income, education, housing quality, and
employment, are associated with disparities in Alzheimer disease and health generally, yet …
employment, are associated with disparities in Alzheimer disease and health generally, yet …
Community-engaged approaches for minority recruitment into clinical research: a scoping review of the literature
ML Wieland, JW Njeru, F Alahdab, CA Doubeni… - Mayo Clinic …, 2021 - Elsevier
Underrepresentation of racial and ethnic minority populations in clinical research persists in
the United States, highlighting the unmet ideals of generalizability and equity of research …
the United States, highlighting the unmet ideals of generalizability and equity of research …
Representativeness of samples enrolled in Alzheimer's disease research centers
M Arce Rentería, TM Mobley… - Alzheimer's & …, 2023 - Wiley Online Library
To generalize findings on the mechanisms and prognosis in Alzheimer's disease and
related dementias (ADRD), it is critical for ADRD research to be representative of the …
related dementias (ADRD), it is critical for ADRD research to be representative of the …
Facilitating Alzheimer disease research recruitment
Alzheimer disease (AD) research faces challenges to successful enrollment, especially to
clinical trials and biomarker studies. Failure to recruit the planned number of participants in a …
clinical trials and biomarker studies. Failure to recruit the planned number of participants in a …
Perspective on the “African American participation in Alzheimer disease research: Effective strategies” workshop, 2018
A Denny, M Streitz, K Stock… - Alzheimer's & …, 2020 - Wiley Online Library
Abstract The Washington University School of Medicine Knight Alzheimer Disease Research
Center's “African American Participation in Alzheimer Disease Research: Effective …
Center's “African American Participation in Alzheimer Disease Research: Effective …
Missing the mark: The complexity of African American dementia family caregiving
Alzheimer's disease and related dementias (ADRDs) have a significant impact on families.
Family nurses are in an ideal position to address the needs of families affected by ADRD …
Family nurses are in an ideal position to address the needs of families affected by ADRD …
Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation
Introduction We sought to examine the association of race/ethnicity with willingness to
engage in studies that involve procedures typical of Alzheimer's disease (AD) clinical trials …
engage in studies that involve procedures typical of Alzheimer's disease (AD) clinical trials …
Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis
A Chaudhry, M Rizig - Journal of the Neurological Sciences, 2021 - Elsevier
Abstract Rationale Biomarker research for Alzheimer's disease (AD) has grown rapidly in
recent years, ensuing the integration of the AD fluid biomarker profile: Aβ1-42, t-tau, and p …
recent years, ensuing the integration of the AD fluid biomarker profile: Aβ1-42, t-tau, and p …